Gynecologic Oncology - ModernMedicine
All Resource Centers / Gynecologic Oncology

Gynecologic Oncology

  • Contemporary OB/GYN Special Delivery

    Radiation for breast cancer, coronary artery stenosis linked



    Women treated for breast cancer with radiotherapy are more likely to develop stenosis in the coronary arteries that are exposed to the greatest amounts of radiation, according to a Swedish study.

  • Ovarian cancer findings support metformin's antitumor effects



    NEW YORK (Reuters Health) - In a review of ovarian cancer outcomes, women with diabetes survived longer if they took metformin -- and on progression-free survival the diabetics who used metformin did better even compared to women who didn't have diabetes at all.

  • Contemporary OB/GYN Special Delivery

    Race, insurance influence treatment of advanced ovarian cancer



    Black and Hispanic women and uninsured or Medicaid-insured women are less likely to receive standard treatment for stage IIIC or IV ovarian cancer, according to a large, multi-institutional cohort study published in Obstetrics and Gynecology (2012;119[1];68-77). MORE

  • CIN 1 does not increase CIN 3 risk beyond HPV infection



    NEW YORK (Reuters Health) - Cervical intraepithelial neoplasia grade 1 (CIN 1) found on biopsy provides no information on the risk of progression to CIN 3 beyond that of a human papillomavirus (HPV) infection, researchers report in the December issue of Obstetrics and Gynecology.

  • Contemporary OB/GYN

    IVF increases risk for ovarian tumors



    Ovarian stimulation for in vitro fertilization (IVF) may double or even quadruple a woman's risk for an ovarian tumor in the next 15 years, According to a cohort study from the Netherlands involving almost 20,000 women who received IVF treatment between 1983 and 1995 and a comparison group of about 6,000 subfertile women not treated with IVF.

  • 2013 results to show if bevacizumab (Avastin) prolongs life in ovarian cancer



    NEW YORK (Reuters Health) - The coauthor of a study that helped convince the European Commission on Friday to approve bevacizumab (Avastin) as an initial post-surgical treatment for advanced ovarian cancer predicted that some doctors may be reluctant to use the drug until mortality data become available in 2013.

  • EU OKs Roche's Avastin (bevacizumab) for ovarian cancer



    ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin (bevacizumab) for treating newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.

  • Uterine fibroids cost the U.S. billions, study finds



    NEW YORK (Reuters Health) - Uterine fibroids cost the U.S. billions each year in lost work days, pregnancy problems and treatments, a new study finds.

  • Asymptomatic women may be getting unneeded pelvic exams: study



    NEW YORK (Reuters Health) - Many women are accustomed to getting a pelvic exam every year, and doctors are accustomed to giving them -- but it's unclear if they serve any real purpose in women without any pelvic pain or signs of infection, say the authors of a new report.

eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here



Click here